Rare Disease Genetic Testing Market Competitive Landscape, Country-Level Breakdown, Segmentation

 The global rare disease genetic testing market size is expected to reach USD 1.8 Billion by 2027 according to a new study by Polaris Market Research. The report “Rare Disease Genetic Testing Market Share, Size, Trends, Industry Analysis Report, By Disease Type (Neurological Disorders, Immunological Disorders, Hematology Ailments, Endocrine & Metabolism Disorders, Cancer, Musculoskeletal Disorders, Cardiovascular Disorders, Dermatology Disorders, Others); By Technology; By Specialty; By End-Use; By Regions; Segment Forecast, 2020 – 2027” gives a detailed insight into current market dynamics and provides analysis on future market growth.

 

The growing need for on-time diagnosis of uncommon disorders, rising prevalence of rare disorders, innovations in genomic testing, and the focused approach of the market player’s in cost-effective treatments are the key factors responsible for market growth. Moreover, government-sponsored schemes are also expected to positively impact the market. In February 2020, the government of India announced financial assistance of INR 15 lacs to the patients suffering from uncommon ailments under the Rashtriya Arogaya Nidhi scheme for a one-time treatment.

 

The global rare disease genetic testing industry is fragmented based on disease type, technology, specialty, end-use, and region. In terms of disease type, the market is segmented into neurological disorders, immunological disorders, hematology illnesses, endocrine & metabolism ailments, cancer, musculoskeletal disorders, cardiovascular disorders, dermatology illnesses, and others.

 

Download Sample Copy: https://www.polarismarketresearch.com/industry-analysis/rare-disease-genetic-testing-market/request-for-sample

 

Based on technology, the rare disease genetic testing industry is further bifurcated into next-generation sequencing, array technology, PCR-based testing, FISH, sanger sequencing, and karyotyping. Based on specialty, the rare disease genetic testing industry is further bifurcated into molecular, chromosomal, and biochemical genomic tests. Based on end-use, the rare disease genomic testing industry is further bifurcated into research laboratories & CROs, hospitals & clinics, and diagnostic laboratories.

​

  

Segment Highlights

• Neurological ailments accounted for the largest revenue share in 2019 on account of the increasing prevalence of neurologic disorders across the globe and presence of numerous testing techniques
• Based on technology, the next generation sequencing segment is projected to constitute almost half of the market in 2027. The usage of the technology in whole genome sequencing is the key factor responsible for its segment’s growth.
• Molecular tests are expected to account for the highest revenue share by the end of 2027. The availability of advanced technologies and ability to test ultra-rare disorders is expected to drive market growth.
• Research laboratories & CROs accounted for the largest revenue share in 2019 owing to the increasing number of tests and growing occurrence of rare disorders across the developed economies

 

List of Key Players

• Strand Life Sciences
• Myriad Genetics
• Quest Diagnostics Inc.
• Centogene N.V.
• Invitae Corporation
• Baylor Genetics
• Ambry Genetics
• Macrogen, Inc.
• Opko Health, Inc.
• Color Genomics, Inc.
• Health Network Laboratories
• Preventiongenetics, Progenity, Inc.
• Fulgent Genetics Inc.
• Others

Do You Have Any Query Or Specific Requirement? Ask to Our Industry Expert @ https://www.polarismarketresearch.com/industry-analysis/rare-disease-genetic-testing-market/speak-to-analyst

 

Polaris Market Research has segmented the rare disease genetic testing market report on the basis of disease type, technology, specialty, end-use, and region

Rare Disease Genetic Testing, Disease Type Outlook (Revenue – USD Million, 2016 – 2027)

• Neurological Disorders
• Immunological Disorders
• Hematology Ailments
• Endocrine & Metabolism Disorders
• Cancer
• Musculoskeletal Disorders
• Cardiovascular Disorders
• Dermatology Disorders
• Others

Rare Disease Genetic Testing, Technology Outlook (Revenue – USD Million, 2016 – 2027)

• Next Generation Sequencing
• Whole Exome Sequencing
• Whole Genome Sequencing
• Array Technology
• PCR-based Testing
• FISH
• Sanger Sequencing
• Karyotyping

Rare Disease Genetic Testing, Specialty Outlook (Revenue – USD Million, 2016 – 2027)

• Molecular Genetic Tests
• Chromosomal Genetic Tests
• Biochemical Genetic Tests

Rare Disease Genetic Testing, Technology Outlook (Revenue – USD Million, 2016 – 2027)

• Research Laboratories & CROs
• Hospitals & Clinics
• Diagnostic Laboratories

Rare Disease Genetic Testing, Regional Outlook (Revenue – USD Million, 2016 – 2027)

• North America
  1. U.S.
  2. Canada
• Europe
  1. France
  2. Germany
  3. UK
  4. Italy
  5. Spain
  6. Netherlands
  7. Austria
• Asia Pacific
  1. China
  2. India
  3. Japan
  4. Malaysia
  5. South Korea
  6. Indonesia
• Central & South America
  1. Mexico
  2. Brazil
  3. Argentina
• Middle East & Africa
  1. UAE
  2. Saudi Arabia
  3. Israel
     • South Africa

Direct Purchase this Market Research Report Now @ https://www.polarismarketresearch.com/checkouts/7391

 

Chemiluminescence Immunoassay Market Dynamics, Forecast, Analysis And Supply Demand 2020 – 2027

 The global chemiluminescence immunoassay market is expected to reach USD 10.67 billion by 2027, according to a new study by Polaris Market Research. The report Chemiluminescence Immunoassay Market Share, Size, Trends, Industry Analysis Report, By Product (Instruments {Automated and Semi-automated}, Consumables, Software & Services); By Application (Therapeutic Drug Monitoring, Oncology, Cardiology, Endocrinology, Infectious Disease, Autoimmune Disease); By End Use; By Regions; Segment Forecast, 2020 – 2027 gives a detailed insight into current market dynamics and provides analysis on future market growth.

 

The global chemiluminescence immunoassay market is driven by few notable factors such as rapid surge in the COVID- 19 cases, the awareness among the people about timely medical attention, and rapidly improving healthcare infrastructure in terms of rapid testing, which in turn, boosting the chemiluminescence immunoassay industry growth. Chemiluminescence immunoassay solutions are also used for detection of numerous severe diseases including autoimmune disease, cancer, and diabetes, among others.

 

Download Sample Copy : https://www.polarismarketresearch.com/industry-analysis/chemiluminescence-immunoassay-market/request-for-sample

 

 

The global chemiluminescence immunoassay industry is segmented on the basis of product, application, end-use, and region. In terms of product, the market is segmented into instruments, consumables, and software and services. Based on application, the market is classified as therapeutic drug monitoring, oncology, cardiology, endocrinology, infectious disease, autoimmune disease, and others. The end-use segment is further divided into hospitals, clinical laboratories, pharmaceutical & biotechnology companies, and others.

  

Segment Highlights

• The consumables segment of chemiluminescence immunoassay industry accounted for the largest revenue share in 2019 and is expected to continue its dominance over the forecast period. This can be attributed to the increasing demand for stains or reagents in therapeutics such as endocrinology and drug monitoring.
• Based on application, the infectious diseases segment is projected to constitute almost half of the market by the end of 2027 on account of the aggressive use of chemiluminescence immunoassay solutions in the healthcare industry to check pandemic infection in across the regions.
• Hospitals segment is expected to account for the largest revenue share by the end of 2027 on account of the increasing footfall in hospitals for the treatment of several infectious diseases and chronic diseases such as cancer driving chemiluminescence immunoassay solutions

 

List of Key Players

• DiaSorin S.p.A.
• Hoffmann-La Roche AG
• Abbott Laboratories
• Immunodiagnostic Systems
• Maccura Biotechnology
• Shenzhen Mindray
• Beckman Coulter Inc.
• Others

Do You Have Any Query Or Specific Requirement? Ask to Our Industry Expert @ https://www.polarismarketresearch.com/industry-analysis/chemiluminescence-immunoassay-market/request-for-customization

Polaris Market Research has segmented the chemiluminescence immunoassay market report on the basis of product, application, end-use, and region.

Chemiluminescence Immunoassay, Product Outlook (Revenue – USD Million, 2016 – 2027)

• Instruments
• Automated
• Semi-automated
• Consumables
• Software & Services

Chemiluminescence Immunoassay, Application Outlook (Revenue – USD Million, 2016 – 2027)

• Therapeutic Drug Monitoring
• Oncology
• Cardiology
• Endocrinology
• Infectious Disease
• Autoimmune Disease
• Others

Chemiluminescence Immunoassay, End Use Outlook (Revenue – USD Million, 2016 – 2027)

• Hospitals
• Clinical Laboratories
• Pharmaceutical & Biotechnology Companies
• Others

Chemiluminescence Immunoassay, Regional Outlook (Revenue – USD Million, 2016 – 2027)

• North America
  • U.S.
  • Canada
• Europe
  • France
  • Germany
  • UK
  • Italy
  • Spain
  • Netherlands
  • Austria
• Asia Pacific
  • China
  • India
  • Japan
  • Malaysia
  • South Korea
  • Indonesia
• Central & South America
  • Mexico
  • Brazil
  • Argentina
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Direct Purchase this Market Research Report Now @ https://www.polarismarketresearch.com/checkouts/7361

 

Cell banking outsourcing Market Segmentation, Forecast, Analysis, Industry Size and Share To 2026

The global cell banking outsourcing market is anticipated to reach USD 4,366.9 Million by 2025 according to a new report published by Polaris Market Research. In 2017, on the basis of type, master cell banking segment capture the largest market shares in terms of revenue and hold the major share in the market. Regionally, North America accounted for the major share in the global cell banking outsourcing market.

 

The global Cell Banking Outsourcing market growth is primarily driven by the rising number of clinical trials which has helped in unmasking the potential of stem cells and their relative applications. Similarly, awareness for stem cell banking across multiple developing countries, and increasing governments initiatives that promote the awareness for stem cell isolation & its related benefits to influence the market growth during the forecast period. Rising research activities related to stem cell applications are expected to support the market growth during the forecast period. Furthermore, increase in the average life expectations due to advanced medical research and improved general lifestyle of the population, and straightforward regulations for the stem cell researchers is expected to create significant potential for this market in coming years. While, increasing number of adipose tissue banking has also become one of the major opportunities.

 

Get Sample PDF @ https://www.polarismarketresearch.com/industry-analysis/cell-banking-outsourcing-market/request-for-sample

 

The global cell banking outsourcing market is segmented on the basis of Type, Product type, cell type and phase. On the basis of type, the market is categorized into Master Cell Banking, Viral Cell Banking, and Working Cell Banking. On the basis of product type, the market is segmented into Cord Cell Banking, Adult Stem Cell Banking, IPS Stem Cell Banking, Embryonic Stem Cell Banking, and IPS Stem Cell Banking. The cell type is further categorized into Stem Cell and Non-Stem Cell. The phase is segmented into bank storage, bank preparation and bank characterization & testing. The bank storage is further sub-segmented into Working Cell Bank Storage, Master Cell Bank Storage, and Cell Storage Stability Testing.

 

By geography, the global Cell Banking Outsourcing market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. In 2017, the North America cell bank outsourcing market was estimated to dominate in terms of revenue. The growth of North American market is majorly driven by the increasing number biopharmaceutical companies & manufacturers and increasing awareness for the use of stem cells as therapeutics proteins and antibiotics in this region. Asia Pacific cell banking outsourcing market is anticipated to be the fastest growing market during the forecast period owing to the increase in the life science sectors with the help of rising number of supportive governments pertaining to investment on biotechnology sector majorly in emerging economies such as China, India and Japan.

 

Get Special Discount Offer @ https://www.polarismarketresearch.com/industry-analysis/cell-banking-outsourcing-market/request-for-discount-pricing

 

Key Findings from the study suggest various therapies available in the market are continuously concentrating on the technological advancements. Increased awareness for use of automation in pharmaceutical industry coupled with high growth in Asia Pacific region due to booming economies of India, and China are factors expected to have positive influence on the global cell banking outsourcing market over the forecast years.

 

The leading operating in the cell banking outsourcing market include BioReliance, Covance, GlobalStem Inc., BSL Bioservice, Cleancells, Charles River Laboratories Lonza, Toxikon Corporation, Cryobanks International India, Wuxi Apptec, Reliance Life Sciences, LifeCell International Pvt. Ltd., BioOutsource (Sartorious), CordLife, PX’Therapeutics SA, SGS Life Sciences, Texcell and Cryo-Cell International Inc among others.

  

Cardiac Rhythm Management Devices Market Segmentation, Forecast, Analysis, Industry Size and Share To 2026

 The global cardiac rhythm management devices market size is expected to touch USD 35.22 billion by 2026 growing at a CAGR of 7.5% from 2019 to 2026, Cardiac rhythm management devices have witnessed evolution of pacemakers, cardiac resynchronization therapy, implantable cardioveter defibrillators and loop recorders over the last decade.  The growth drivers for the market include favorable legislative policies followed by Government in developed and developing countries. Additional market drivers include rising incidence of cardiovascular diseases (CVD’s), cohesive reimbursement climate and technological advancements that boost market growth

 

CRM devices are the universal solution for patients suffering from arrhythmias. Latest findings in Cardiac Resynchronization therapy devices are anticipated to drive this market.  Furthermore, implantable cardioverter-defibrillators have opened up more vistas of operations since their integration with pacemakers.  This increases the product life for pacemakers. Cardioverter- defibrillators having found immense applications are certain to expand market growth.

 

Get Sample Copy @   https://www.polarismarketresearch.com/industry-analysis/cardiac-rhythm-management-devices-market/request-for-sample

 

Sudden Cardiac Arrest (SCA) is also debilitating human population that explains high growth of external defibrillators. Government initiatives are working in the direction of making economies more cardio-friendly. This works positively for external debrifillators to experience surging market growth.

 

As per Government data available More than 6.0 million people have fallen prey to cardiac disorders. Of these, 0.8 million are victims of atrioventricular blockage that ends in cardiac failure. This proves an outgo of USD 20-60 billion annually. Hence to prevent this, CRM devices are being put to effective use to prevent surgical costs from inflating and also prevents readmission charges, thus impacting market growth.

            

North America took credit of nearly 35% overall market for CRM Devices in 2016. This was particularly due to supportive legislative policies, lenient reimbursement schemes and increase in cardiovascular diseases. Asia Pacific was seen as fast growing market for CRM devices with a CAGR of 9%. This was largely made possible due to accessibility of CRM devices.

 

Do you have questions or special requirements? Ask our industry experts @ https://www.polarismarketresearch.com/industry-analysis/cardiac-rhythm-management-devices-market/speak-to-analyst

 

The key players operating in Cardiac Rhythm Management Devices Implantation include St, Jude Medical, BIOTRONIK, Inc., Medtronic and Boston Scientific Corporation and ZOLL Medical Corporation among others.

 

Polaris Market Research has segmented the global Cardiac Rhythm Management (CRM) market on the basis of product and Region:

 

CRM Devices Product Outlook (Revenue USD Millions 2015-2026)

• Pacemakers
• Implantable Pacemakers
• External pacemakers
• Defibrillators
• Implantable Cardioverter Defibrillator
• Subcutaneous ICD
• Transvenous ICD
• External Defribillator
• Manual ED
• Automated ED
• Wearable Cardioverter Defibrillator
• Cardiac Resynchronization Therapy (CRT)
• CRT- Defibrillators
• CRT-Pacemakers

 

Lithium Iron Phosphate Battery Market Segmentation, Forecast, Analysis, Industry Size and Share To 2026

 The global Lithium Iron Phosphate (LiFePO4) Battery market is anticipated to reach USD 34.5 billion by 2026, according to a new research published by Polaris Market Research. In 2017, the automotive segment dominated the global market, in terms of revenue. Asia-Pacific is expected to be the leading contributor to the global Lithium Iron Phosphate Battery market revenue during the forecast period.

 

The rising demand of Lithium Iron Phosphate battery from the automotive sector primarily drives the growth of Lithium Iron Phosphate Battery market. The demand for battery electric vehicles has increased significantly over the years resulting in increasing adoption of Lithium Iron Phosphate batteries. The exponential growth in the prices of gasoline and diesel owing to the depleting fossil fuel reserves, along with increasing environmental concerns has encouraged consumers to switch to battery electric vehicles. Technological advancements, rising adoption of smart devices, stringent government mandates, and increasing applications are factors expected to further increase the demand of lithium iron phosphate batteries during the forecast period.

 

Get Sample Copy @ https://www.polarismarketresearch.com/industry-analysis/lithium-iron-phosphate-lifepo4-battery-market/request-for-sample

 

Asia-Pacific generated the highest revenue in the market in 2017, and is expected to lead the global Lithium Iron Phosphate Battery market throughout the forecast period. The increasing demand for electric vehicles in the region is expected to drive the growth of Lithium Iron Phosphate batteries in this region. The growing use of Lithium Iron Phosphate batteries in renewable energy storage systems also accelerates the adoption. The increasing demand for consumer electronics from countries such as China, Japan, and India, along with stringent government regulations boost the Lithium Iron Phosphate Battery market growth.

 

The companies operating in the Lithium Iron Phosphate Battery market include Panasonic Corporation, Toshiba Corporation, Samsung SDI Co., Ltd, Toshiba Corporation, BYD Company Ltd., GS Yuasa Corporation, Valence Technology, Inc., A123 Systems, LLC., Formosa Energy & Material Technology, and Bharat Power Solutions. These companies launch new products and collaborate with other market leaders to innovate and launch new products to meet the increasing needs and requirements of consumers.

 

Get Special Discount On this Research Report @ https://www.polarismarketresearch.com/industry-analysis/lithium-iron-phosphate-lifepo4-battery-market/request-for-discount-pricing

IoT Microcontroller Market Trends and Vendors Analysis after Covid-19 Pandemic Opportunities

The IoT microcontroller market is anticipated to reach over USD 5,170 million by 2026 according to a new research published by Polaris Market Research. In 2017, the 32 bit microcontroller segment dominated the global IoT microcontroller market, in terms of revenue. North America was the leading contributor to the global market revenue in 2017.

 

The growing penetration of mobile devices, and increasing adoption of IoT has primarily driven the growth of the IoT microcontroller market. The rising adoption of virtualization, cloud, and big data analytics has supported market growth over the years. Increasing investments by vendors in technological advancements coupled with growing automation across diverse industries would accelerate the growth of the IoT Microcontroller market during the forecast period. However, high power consumption, security and privacy concerns, and lack of standardization hinder the market growth. Growing demand from emerging economies, ad technological advancements are expected to provide numerous growth opportunities in the coming years.

 

Get Sample Copy @ https://www.polarismarketresearch.com/industry-analysis/iot-microcontroller-market/request-for-sample

 

North America generated the highest revenue in the market in 2017. The increase in industrial automation, and growing number of mobile devices drive the market growth. The growing trend of BYOD, IoT, big data analytics, and virtualization increases the demand for IoT microcontroller in the region. The growing penetration of mobile devices, and technological advancements further support IoT microcontroller market growth in the region. The increasing spending on smart homes and smart cities in the region further promote market growth in the region. Asia-Pacific is expected to grow at the highest CAGR during the forecast period owing to growing automation of industrial processes across various industries in the developing countries of the region.

 

The companies operating in the market include Infineon Technologies, Broadcom Corporation, Microchip Technology, Fujitsu Ltd, Holtek Semiconductor, Silicon Laboratories, Inc, Texas Instruments, NXP Semiconductors N.V, Atmel Corporation, and Espressif Systems Pte. Ltd. These companies launch new products and collaborate with other market leaders to innovate and launch new products to meet the increasing needs and requirements of consumers.

 

Get Special Discount On this Research Report @ https://www.polarismarketresearch.com/industry-analysis/iot-microcontroller-market/request-for-discount-pricing

 

Electric Power Distribution Automation Systems Market Segmentation, Forecast, Analysis, Industry Size and Share To 2026

The Electric Power Distribution Automation Systems Market is anticipated to reach around USD 23.8 billion by 2026 according to a new research published by Polaris Market Research. In 2017, the industrial segment dominated the global market, in terms of revenue. North America is expected to be the leading contributor to the global market revenue during the forecast period. 

 

The growing adoption of smart cities, along with high demand of smart grids has boosted the adoption of electric power distribution automation systems. The rising demand for electricity, and growing demand for efficient and low-cost solutions for efficient power distribution further support the growth of electric power distribution automation systems market. Increasing investments by vendors in technological advancements, growing need to update existing networks, and increasing ageing infrastructure would accelerate the adoption of electric power distribution automation systems during the forecast period. Growing demand from emerging economies, increasing adoption smart grid applications, and technological advancements are expected to provide numerous growth opportunities in the coming years.

 

Get Sample Copy : https://www.polarismarketresearch.com/industry-analysis/electric-power-distribution-automation-systems-market/request-for-sample

 

North America generated the highest revenue in the market in 2017, and is expected to lead the global market throughout the forecast period. The presence of established telecom and cloud infrastructure in this region, and growing trend of smart cities drive the market growth in the region. The growing demand from energy sector, and technological advancements further support market growth in the region. The use of smart technologies in energy and utilities, investments in transmission and distribution infrastructure, and increasing ageing infrastructure is expected to support market growth in this region during the forecast period.

 

The companies operating in the market include General Electric, Eaton Corporation Plc, Mitsubishi Electric Corp., ABB Ltd., G&W Electric Company, Schneider Electric, Elster Solutions, Schweitzer Engineering Laboratories, Siemens AG, and S&C Electric Company. These companies launch new products and collaborate with other market leaders to innovate and launch new products to meet the increasing needs and requirements of consumers.

 

Get Discount Offer : https://www.polarismarketresearch.com/industry-analysis/electric-power-distribution-automation-systems-market/request-for-discount-pricing

Voice and speech recognition Market Segmentation, Forecast, Analysis, Industry Size And Share To 2027

The global speech and voice recognition market size is expected to grow to USD 31.49 billion by 2026 according to a new report published by Polaris Market Research. The report “Voice and Speech Recognition Market Share, Size, Trends, Industry Analysis Report By Component (Hardware, Software, Services); By Interface (AI-Based, Non-AI Based); By End-User (Automotive, Healthcare, BFSI, Consumer, Retail, Government, Home security & Automation, Others); By Regions, Segments & Forecast, 2019 – 2026”, provides step-by-step analysis into current market insights and detailed analysis of future market trends.

 

In 2018, the non AI-based voice and speech recognition segment dominated the global market in terms of revenue. North America is expected to be the leading contributor to global market revenue during forecast period. A currently moving demand for virtual assistants at homes and enterprises supports the growth of this market. A growing need for automation in customer service and integration of virtual assistants with smart home appliances (digital homes) drive the growth of market. A need to streamline enterprise communication to improve productivity further supports market growth. Other driving factors include increased use in automobiles, mobile banking applications and Electronic health record applications (EHR). The increasing use in biometric applications for user voice authentication would boost market growth during forecast period. A surging demand from emerging economies and technological advancements are factors expected to provide several growth opportunities in coming years.

 

Download Sample Copy @ https://www.polarismarketresearch.com/industry-analysis/voice-recognition-market/request-for-sample

 

An upward interest shone through in cars sector and expanding modernization of vehicles drove showcase development. The thought process being voice acknowledgements diminish mistakes enhancing market effectiveness. IT has been foreseen that half of ventures will be voice essays by 2020.  An increasing number of data lapses such as security attacks give reasonable credence to voice recognition systems that are more reliable authentication methods. Growing number of security concerns drive market.

  

North America came up with highest revenue in the market in 2017 and is anticipated to lead market gains through the forecast period. Use of intelligent virtual assistants to replace traditional interactive response systems has boosted market growth in the region. Use of intelligent virtual assistants is proving effective by enhancing customer and brand experience providing a consumer-friendly environment. The presence of established telecom and cloud infrastructure in the region and growing trend of BYOD drive the market growth in the region. The demand for voice recognition systems has grown significantly in BFSI and healthcare sectors in the regions. Increased adoption of smart homes and smart buildings would provide opportunities for market during forecast period.

 

China is the world’s largest populace and is expected to have high adoption rates for these technologies. The number of mobile transactions has reportedly increased which makes it ideal for implementation of this software.

 

Get Special Discount On Complete Report @ https://www.polarismarketresearch.com/industry-analysis/voice-recognition-market/request-for-discount-pricing

 

 

Market players are introducing new products in the market to cater to a growing customer base and players are venturing into new markets to expand customer portal and make market presence strong.

 

The companies in the speech and voice recognition market include Google, Inc., Baidu, Inc., Facebook, Inc., Amazon.com, Inc., Advanced Voice Recognition Systems, Inc., Apple, Inc., IBM Corporation, Microsoft Corporation, Briana soft, VoiceBox Technologies, Fulcrum Biometrics, Neurotechnology, M2SYS Biometrics, Sensory Inc., Voice Base, INc., Agnitio Corp., Auraya Systems, VoiceTrust and Nuance Communications.